CCRM Australia
CCRM Australia is the Australian Hub of the highly successful Centre for Commercialization of Regenerative Medicine in Canada (CCRM). Established as a not-for-profit with a national focus, CCRM Australia’s mission is to address bottlenecks in the translation and commercialization of regenerative medicine discoveries in Australia, many of which have the potential to cure some of the most devastating and costly diseases in the world today. CCRM Australia’s commercially focused solutions enable businesses and research partners to achieve their commercialization objectives by providing customized country, market and industry-specific support. To date, CCRM Australia has collaborated with researchers to advance their regenerative medicine technologies, evaluated and supported promising technologies to seek investment funding, facilitated commercialization training and worked with international biotechnology companies to set up their clinical trials in Australia. CCRM Australia continues to do so, while providing access to resources and expertise from other CCRM Hubs around the world.
Posts by: CCRM Australia
Target product profile: Starting that journey of a thousand miles with the right first step
This post is by Harmanpreet Harmanpreet, who interned with CCRM Australia. The CCRM Australia Training Program seeks to facilitate training for the future workforce of the Australian regenerative medicine sector and includes an internship program that accepts undergraduate and postgraduate students from Australia’s universities. Approximately 25 per cent of late-phase clinical trials fail due to […]
CCRM Australia Internships: exciting the next generation of bio-entrepreneurs
By Bhavi Kadakia, Dharvi Patel, Harmanpreet Harmanpreet, Mahmuda Khatun. Edited by Dr. Chih Wei Teng Mentorship? Check. Challenging and relevant projects? Check. Access to industry events and thought leadership? Check. Is there a spot open for you? Check. The CCRM Australia Training Program seeks to facilitate training for the future workforce of the Australian regenerative […]
Cell therapies: how much will we pay?
Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia and wrote this blog with colleagues Alex Barrington and Dr. Emma Gallaher. To subscribe to the CCRM Australia newsletter: Click here As stem cell therapies move through clinical trials and get closer to the clinic, they are giving rise to new challenges, primarily around costs […]
Sensors, the long-desired safety net for regenerative medicine
Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia and wrote this blog with colleagues Alex Barrington and Dr. Emma Gallaher. To subscribe to the CCRM Australia newsletter: Click here Regenerative medicine is a risky business. The decades-long development pipeline and the expenditure of millions of dollars presents itself as an insurmountable mountain […]
Leveraging Australia’s existing foundation for impact
Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia. Regulatory reforms, significant investments into infrastructure and focused grand challenge programs are very much like an economic and science arms race to develop the next blockbuster or vaccine, such as the current race to address the COVID-19 pandemic. Countries around the world are making […]